Largo Hospital expands treatment options with innovative histotripsy technology for liver tumors
Largo, FL — HCA Florida Largo Hospital is proud to announce the expansion of its advanced cancer care services with the arrival of histotripsy technology, a groundbreaking, non-invasive treatment option for patients with liver tumors.
Histotripsy uses focused ultrasound energy, precise sound waves, to mechanically break down targeted tumor tissue without the use of incisions, heat or radiation. This pioneering treatment offers a new level of precision and safety, allowing for faster recovery times and reduced complications compared to traditional therapies.
“We’re excited to bring this transformative technology to our community,” said Rafik Lababidi, MD, interventional radiologist at HCA Florida Largo Hospital. “This technology provides our team with a new tool to treat liver tumors in a way that’s less invasive, more precise and ultimately will improve quality of life for our patients.”
The addition of histotripsy further solidifies HCA Florida Largo Hospital’s position as a leader in advanced liver care and minimally invasive therapies. The hospital continues to invest in innovative technologies and multidisciplinary approaches that enhance outcomes for complex conditions, including liver disease and cancer.
“Offering histotripsy underscores our commitment to providing patients with access to the latest and most effective treatment options,” shared Sebastian Strom, MD, chief executive officer of HCA Florida Largo Hospital.